[{"address1": "295 Rokeby Road", "address2": "Suite 1", "city": "Subiaco", "state": "WA", "zip": "6008", "country": "Australia", "phone": "61 8 6555 2950", "fax": "61 8 6166 0261", "website": "https://argentbiopharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Argent BioPharma Limited, a drug discovery clinical-stage biopharmaceutical company, provides medicines targeting immunology and neurology worldwide. Its principal product candidates include CimetrA, which is in phase II clinical trial for the treatment of SLE Lupus, anti-inflammatory, and SARS COVID-19; and CannEpil, which is in phase I clinical trial for refractory epilepsy and cerebral palsy; and CogniCann, which is in phase I clinical trial for the symptomatic relief of Dementia and Alzheimer. In addition, the company provides Irnican for brain cancer. The company was formerly known as MGC Pharmaceuticals Limited and changed it name to Argent BioPharma Limited. Argent BioPharma Limited was founded in 2014 and is based in Subiaco, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Roby Reuven Zomer", "age": 43, "title": "Co-Founder, CEO, MD & Executive Director", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 238831, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Igor  Bluvstein", "age": 41, "title": "Chief Financial Officer", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yifat  Steuer", "title": "Deputy CEO & COO", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tom  Cairns", "title": "Chief Accounting Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Nicole Ann Godresse", "title": "Global Chief Sales Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Amir  Polak", "title": "Chief Pharmaceutical Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sabina  Suljakovic", "title": "Head of the Quality Assurance Department", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Nadya  Lisovoder", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sasha  Friedman", "title": "Deputy CEO", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Yair  Tal", "title": "Chief Information Security Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.19, "open": 0.2612, "dayLow": 0.255, "dayHigh": 0.265, "regularMarketPreviousClose": 0.19, "regularMarketOpen": 0.2612, "regularMarketDayLow": 0.255, "regularMarketDayHigh": 0.265, "beta": 1.076, "volume": 21000, "regularMarketVolume": 21000, "averageVolume": 41383, "averageVolume10days": 213200, "averageDailyVolume10Day": 213200, "bid": 0.216, "ask": 0.28, "marketCap": 17789006, "fiftyTwoWeekLow": 0.14, "fiftyTwoWeekHigh": 2.2, "priceToSalesTrailing12Months": 13.4311695, "fiftyDayAverage": 0.21985, "twoHundredDayAverage": 0.285758, "currency": "USD", "enterpriseValue": 9779059, "floatShares": 22331054, "sharesOutstanding": 45280200, "heldPercentInsiders": 0.07387, "heldPercentInstitutions": 0.01126, "impliedSharesOutstanding": 68577504, "bookValue": 0.037, "priceToBook": 7.010811, "lastFiscalYearEnd": 1688083200, "nextFiscalYearEnd": 1719705600, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -17017830, "trailingEps": -2.16, "lastSplitFactor": "1:1000", "lastSplitDate": 1698624000, "enterpriseToRevenue": 7.383, "enterpriseToEbitda": -0.677, "52WeekChange": -0.88235295, "SandP52WeekChange": 0.28438115, "exchange": "OQB", "quoteType": "EQUITY", "symbol": "RGTLF", "underlyingSymbol": "RGTLF", "shortName": "ARGENT BIOPHARMA LIMITED", "longName": "Argent BioPharma Limited", "firstTradeDateEpochUtc": 1487773800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "9098593c-70ad-3888-bfa6-98866814ab6b", "messageBoardId": "finmb_146284473", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.2594, "recommendationKey": "none", "totalCash": 6482268, "totalCashPerShare": 0.178, "ebitda": -14442450, "totalDebt": 9647105, "quickRatio": 0.565, "currentRatio": 0.755, "totalRevenue": 1324457, "debtToEquity": 1436.124, "revenuePerShare": 0.1, "returnOnAssets": -0.58961, "freeCashflow": -6567507, "operatingCashflow": -13137106, "revenueGrowth": -0.775, "grossMargins": 0.09467, "operatingMargins": -13.43419, "financialCurrency": "AUD", "trailingPegRatio": null, "__fetch_time": "2024-08-22"}]